120 related articles for article (PubMed ID: 29232580)
1. Design and synthesis of novel quinacrine-[1,3]-thiazinan-4-one hybrids for their anti-breast cancer activity.
Solomon VR; Pundir S; Le HT; Lee H
Eur J Med Chem; 2018 Jan; 143():1028-1038. PubMed ID: 29232580
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and characterization of novel quinacrine analogs that preferentially kill cancer over non-cancer cells through the down-regulation of Bcl-2 and up-regulation of Bax and Bad.
Solomon VR; Almnayan D; Lee H
Eur J Med Chem; 2017 Sep; 137():156-166. PubMed ID: 28586716
[TBL] [Abstract][Full Text] [Related]
3. New derivative of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-one (BChTT) elicits antiproliferative effect via p38-mediated cell cycle arrest in cancer cells.
Juszczak M; Walczak K; Matysiak J; Lemieszek MK; Langner E; Karpińska MM; Pożarowski P; Niewiadomy A; Rzeski W
Bioorg Med Chem; 2016 Mar; 24(6):1356-61. PubMed ID: 26897091
[TBL] [Abstract][Full Text] [Related]
4. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem; 2006 May; 14(9):2985-93. PubMed ID: 16406643
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of 2,3-diarylated 2H-benzo[e][1,2]thiazine 1,1-dioxides and their 3,4-dihydro derivatives, and assessment of their inhibitory activity against MCF-7 breast cancer cells.
Shan YY; Zhang CM; Tang LQ; Liu ZP; Bearss NR; Sarver JG; Luniwal A; Erhardt PW
Med Chem; 2011 Nov; 7(6):561-71. PubMed ID: 22313296
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.
Viswas RS; Pundir S; Lee H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):620-630. PubMed ID: 30727782
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
11. Design, regioselective synthesis and cytotoxic evaluation of 2-aminoimidazole-quinoline hybrids against cancer and primary endothelial cells.
Singh K; Verma V; Yadav K; Sreekanth V; Kumar D; Bajaj A; Kumar V
Eur J Med Chem; 2014 Nov; 87():150-8. PubMed ID: 25247771
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y
Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-ones, their lipophilicity and anticancer activity in vitro.
Matysiak J; Juszczak M; Karpińska MM; Langner E; Walczak K; Lemieszek MK; Skrzypek A; Niewiadomy A; Rzeski W
Mol Divers; 2015 Nov; 19(4):725-36. PubMed ID: 25920594
[TBL] [Abstract][Full Text] [Related]
14. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
15. Novel 3-Amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine Derivatives with Anticancer Activity: Synthesis and QSAR Study.
Pogorzelska A; Sławiński J; Brożewicz K; Ulenberg S; Bączek T
Molecules; 2015 Dec; 20(12):21960-70. PubMed ID: 26690109
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
